What is the recommended evaluation and management for rhinorrhea?

Evaluation and Management of Rhinorrhea

Begin by distinguishing allergic from nonallergic rhinorrhea through history and targeted testing, then treat allergic rhinorrhea with intranasal corticosteroids as first-line therapy, while nonallergic rhinorrhea with predominant rhinorrhea responds best to intranasal anticholinergics. 1

Initial Evaluation

Key Historical Features to Elicit

Focus your history on these specific discriminating features 1:

For Allergic Rhinorrhea:

• Pruritus and sneezing (much more common than in nonallergic)
• Seasonal exacerbations
• Onset before age 20 years
• Symptoms triggered by specific allergen exposures

For Nonallergic Rhinorrhea:

• Isolated rhinorrhea triggered by eating (gustatory rhinitis)
• Symptoms triggered by strong odors (perfume, tobacco smoke) suggesting vasomotor rhinitis
• Chronic topical decongestant use (rhinitis medicamentosa)
• Isolated postnasal drainage (less likely allergic)

Red Flags Requiring Different Workup:

• Unilateral symptoms suggest structural problems (polyp, foreign body, septal deformity, tumor)
• Hyposmia/anosmia may indicate nasal polyposis
• Clear unilateral discharge that worsens with leaning forward suggests CSF rhinorrhea—confirm with beta-2 transferrin testing 1, 2

Physical Examination

Examine nasal mucosa appearance, patency, unilaterality/bilaterality, anatomical obstruction, and discharge quality/quantity 1. Note that mucosal pallor, edema, or hyperemia do not reliably distinguish allergic from nonallergic rhinitis 1.

Diagnostic Testing

For suspected allergic rhinorrhea: Confirm with specific IgE testing—skin testing is preferred over in vitro testing (70-75% sensitivity) 1. Testing is only meaningful when positive results correlate with exposure history 1.

For suspected CSF rhinorrhea: Beta-2 transferrin in nasal secretions is the most sensitive confirmatory test 1, 2.

Treatment Algorithm

Allergic Rhinorrhea

First-line therapy: Intranasal corticosteroids 1, 3

• Most effective single agent for rhinorrhea, congestion, sneezing, and itching
• Superior to oral antihistamines and leukotriene antagonists

Second-line options:

• Oral second-generation antihistamines (fexofenadine, loratadine, desloratadine, cetirizine) effectively reduce rhinorrhea, sneezing, and itching but have minimal effect on congestion 1

  • Prefer second-generation over first-generation due to sedation, performance impairment, and anticholinergic effects with first-generation agents 1
  • Continuous treatment is more effective than intermittent use 1

• Intranasal antihistamines are equal or superior to oral antihistamines and can be used as first-line treatment 1

Combination therapy:

• Intranasal corticosteroid + oral antihistamine provides additive benefit without increased adverse effects 1
• Leukotriene antagonists + antihistamines may be additive but are generally less efficacious than intranasal corticosteroids 1

Adjunctive therapy:

• Intranasal anticholinergics (ipratropium bromide) effectively reduce rhinorrhea when combined with intranasal corticosteroids, more effective than either alone 1
• Allergen avoidance measures should be implemented early 1

Nonallergic Rhinorrhea

For predominant rhinorrhea (e.g., gustatory rhinitis):

• Intranasal anticholinergics are first-line 1, 4
• Effectively reduce rhinorrhea with minimal side effects (possible nasal membrane dryness) 1

Alternative options:

• Intranasal corticosteroids and intranasal antihistamines may relieve both congestion and rhinorrhea in vasomotor rhinitis 1
• Important: Oral nonsedating antihistamines are NOT effective in nonallergic rhinitis 1

For rhinitis medicamentosa:

• Discontinue nasal decongestant sprays immediately
• Treat with intranasal or systemic corticosteroids 1

Common Pitfalls to Avoid

1. Do not use oral antihistamines for nonallergic rhinorrhea—they are ineffective 1

2. Avoid first-generation antihistamines unless specific benefits (sleep induction, reduced rhinorrhea at bedtime) outweigh risks of sedation and performance impairment 1

3. Do not use parenteral corticosteroids—single-dose is discouraged, recurrent use is contraindicated due to long-term side effects 1

4. Limit oral/topical decongestants to short-term use; use with caution in elderly, young children, and patients with cardiac arrhythmia, hypertension, glaucoma, or hyperthyroidism 1

5. Do not rely on physical examination alone to distinguish allergic from nonallergic rhinitis—mucosal appearance overlaps significantly 1

When to Refer to Allergist/Immunologist

Refer when 1:

• Prolonged manifestations despite treatment
• Complications (otitis media, sinusitis, nasal polyposis)
• Comorbid asthma or chronic sinusitis
• Required systemic corticosteroids
• Symptoms interfere with sleep or work/school performance
• Significantly decreased quality of life
• Treatment ineffective or produces adverse events
• Rhinitis medicamentosa diagnosis
• Need for allergen identification or immunotherapy consideration
• Multiple/costly medications required over prolonged period

Follow-Up Assessment

Evaluate treatment response by assessing 1:

• Nasal symptoms (congestion, itching, rhinorrhea)
• Physical signs (turbinate edema)
• Quality of life (sleep, work/school function)
• Comorbid conditions (asthma control may improve with rhinitis control)